Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Puerto Rico Heart Health Program (PRHHP-BioLINCC)

ABSTRACT: Puerto Rico Heart Health Program (PRHHP-BioLINCC)

PROVIDER: PRJNA1223537 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Puerto Rico Heart Health Program (PRHHP-BioLINCC)

Project description:Puerto Rico Heart Health Program (PRHHP-BioLINCC)

| PRJNA1223539 | ENA

Emerging genomic assays for identification of chikungunya virus infection in asymptomatic blood donors from Puerto Rico, 2014

Project description:The Virochip microarray (version 5.0, Viro5AGL-60K platform) was used to verify the presence or absence of Chikungunya virus in RNA extracts from asymptomatic blood donors located in Puerto Rico.

2015-03-25 | GSE67234 | GEO

Honolulu Heart Program (HHP-BioLINCC)

Project description:Honolulu Heart Program (HHP-BioLINCC)

| PRJNA1216678 | ENA

Honolulu Heart Program (HHP-BioLINCC)

Project description:Honolulu Heart Program (HHP-BioLINCC)

| PRJNA1216677 | ENA

Bacterial fractions produced by Moon snail egg mass associated bacteria from Puerto Rico

Project description:Bacterial fractions produced by Moon snail egg mass associated bacteria from Puerto Rico with S. aureus biofilm inhibition activity.

2025-03-18 | MSV000097361 | MassIVE

Puerto Rico Insecticide Resistance Amplicons

Project description:Puerto Rico Insecticide Resistance Amplicons

| PRJEB72548 | ENA

Puerto Rico Trench Marine Metagenome

Project description:Puerto Rico Trench Marine Metagenome

| PRJNA70477 | ENA

Protein and cytokine profiles associated with COVID-19 disease severity in Puerto Rico

Project description:Viral strains, age, and host factors including genetics and proteins are associated with variable immune responses against SARS-CoV-2 and disease severity. We hypothesized that unique proteins/pathways are associated with COVID-19 disease severity in Puerto Rican Hispanics. A total of 121 men and women aged 21-80 years-old were recruited in Puerto Rico. Plasma samples were collected from unvaccinated COVID-19 infected subjects during acute disease (n=39) and compared to COVID-19 negative individuals (n=56) during acute disease using proteomics and cytokine expression. Infected individuals were stratified based on symptomatology as follows: mild (n=18), moderate (n=13), and severe (n=8). Quantitative proteomics was performed in plasma samples using Tandem Mass Tag (TMT) labeling. Cytokines in plasma were quantified using a human cytokine array. Proteomics analyses revealed 56 differentially regulated proteins and the top 3 pathways that were predicted to be inhibited in severe patients including LXR/RXR signaling, Production of NO and ROS in macrophages, and Synaptogenesis signaling. Decreased cadherin-13 validated by ELISA, which participates in synaptogenesis, is a novel protein is a novel protein not previously reported in other studies of COVID-19 severity and validated by ELISA. Cytokine analyses showed that TNF⍺ levels decreased with disease severity. This study uncovers potential host predictors of COVID-19 severity and new avenues for treatment in Puerto Rican Hispanics.

2024-06-16 | PXD046103 | Pride

Small RNA-Seq of influenza A/Puerto Rico/8/1934 (H1N1) virus infected A549 human cells

Project description:To study expression pattern of small nucleolar RNAs (snoRNAs) during influenza A viral infection, human cells A549 were infected with influenza A/Puerto Rico/8/1934 (H1N1) virus. Small RNA-seq analysis of infected cells after 24 h or 48 h incubation was performed on an Illumina NextSeq 500 platform. The same mock-infected cells were used as control. Small RNA fractions (<200 nucleotide length) was used for constructing of cDNA libraries. Differential expressed non-coding RNAs were identified using R package DESeq2.

2022-11-01 | E-MTAB-12088 | biostudies-arrayexpress

Homo sapiens strain:(PUR) Puerto Rican in Puerto Rico

Project description:CompleteGenomics sequencing of (PUR) Puerto Rican in Puerto Rico

| PRJNA177966 | ENA